将资源使用考量纳入分级建议中。
Incorporating considerations of resources use into grading recommendations.
作者信息
Guyatt Gordon H, Oxman Andrew D, Kunz Regina, Jaeschke Roman, Helfand Mark, Liberati Alessandro, Vist Gunn E, Schünemann Holger J
机构信息
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada L8N 3Z5.
出版信息
BMJ. 2008 May 24;336(7654):1170-3. doi: 10.1136/bmj.39504.506319.80.
Abstract
Guideline panellists have differing opinions on whether resource use should influence decisions on individual patients. As medical care costs rise, resource use considerations become more compelling, but panellists may find dealing with such considerations challenging
摘要
对于资源利用是否应影响针对个体患者的决策，指南小组成员存在不同意见。随着医疗成本上升，对资源利用的考量变得更具说服力，但小组成员可能会发现应对此类考量颇具挑战性。
相似文献
1
Incorporating considerations of resources use into grading recommendations.
BMJ. 2008 May 24;336(7654):1170-3. doi: 10.1136/bmj.39504.506319.80.
2
[GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence].
Z Evid Fortbild Qual Gesundhwes. 2013;107(3):256-68. doi: 10.1016/j.zefq.2013.04.006. Epub 2013 May 24.
3
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence.
J Clin Epidemiol. 2013 Feb;66(2):140-50. doi: 10.1016/j.jclinepi.2012.04.012. Epub 2012 Aug 3.
4
Clinical guidelines: developing guidelines.
BMJ. 1999 Feb 27;318(7183):593-6. doi: 10.1136/bmj.318.7183.593.
5
Self-reported healthcare decision-makers' attitudes towards economic evaluations of medical technologies.
Curr Med Res Opin. 2008 Nov;24(11):3049-58. doi: 10.1185/03007990802442695. Epub 2008 Oct 2.
6
Expanded programme on immunization. Global Advisory Group--Part I.
Wkly Epidemiol Rec. 1992 Jan 17;67(3):11-5.
7
Allocating resources.
Int J Technol Assess Health Care. 1990;6(1):77-92. doi: 10.1017/s0266462300008941.
8
Clinical governance: opportunity or Pandora's box?
Hosp Med. 1999 Jul;60(7):470-1. doi: 10.12968/hosp.1999.60.7.1148.
9
American College of Chest Physicians evidence-based guidelines--the next generation: considering resource use and evolution to a single grading system.
Chest. 2006 Jan;129(1):10-2. doi: 10.1378/chest.129.1.10.
10
The high cost of medicine: decision time.
N Z Med J. 1985 Jul 10;98(782):545-8.
引用本文的文献
1
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study.
JAMA Otolaryngol Head Neck Surg. 2025 Apr 10. doi: 10.1001/jamaoto.2025.0160.
2
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.
Transplantation. 2025 Jul 1;109(7):1066-1110. doi: 10.1097/TP.0000000000005374. Epub 2025 Apr 9.
3
Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections.
Infect Chemother. 2024 Sep;56(3):308-328. doi: 10.3947/ic.2024.0038. Epub 2024 Aug 2.
4
International Digestive Endoscopy Network Consensus on the Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy.
Gut Liver. 2024 Sep 15;18(5):764-780. doi: 10.5009/gnl240176. Epub 2024 Sep 3.
5
Essential oils mouthwash with or without alcohol in relation to effect on parameters of plaque and gingivitis: A systematic review and meta-analysis.
Int J Dent Hyg. 2025 Feb;23(1):186-202. doi: 10.1111/idh.12843. Epub 2024 Aug 12.
6
Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT).
Updates Surg. 2024 Jun;76(3):725-741. doi: 10.1007/s13304-024-01845-z. Epub 2024 May 7.
7
Implementation of an audit and feedback module targeting low-value clinical practices in a provincial trauma quality assurance program: a cost-effectiveness study.
BMC Health Serv Res. 2024 Apr 18;24(1):479. doi: 10.1186/s12913-024-10969-2.
8
International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy.
Clin Endosc. 2024 Mar;57(2):141-157. doi: 10.5946/ce.2024.002. Epub 2024 Mar 14.
9
The effect of movement representation techniques on ankle function and performance in persons with or without a lateral ankle sprain: a systematic review and meta-analysis.
BMC Musculoskelet Disord. 2023 Oct 4;24(1):786. doi: 10.1186/s12891-023-06906-9.
10
Guidelines for Infection Control and Burnout Prevention in Healthcare Workers Responding to COVID-19.
Infect Chemother. 2023 Mar;55(1):150-165. doi: 10.3947/ic.2022.0164.
本文引用的文献
1
Going from evidence to recommendations.
BMJ. 2008 May 10;336(7652):1049-51. doi: 10.1136/bmj.39493.646875.AE.
2
What is "quality of evidence" and why is it important to clinicians?
BMJ. 2008 May 3;336(7651):995-8. doi: 10.1136/bmj.39490.551019.BE.
3
Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force.
Chest. 2006 Jan;129(1):182-7. doi: 10.1378/chest.129.1.182.
4
Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial.
BJOG. 2006 Feb;113(2):144-51. doi: 10.1111/j.1471-0528.2005.00785.x.
5
Users' guide to detecting misleading claims in clinical research reports.
BMJ. 2004 Nov 6;329(7474):1093-6. doi: 10.1136/bmj.329.7474.1093.
6
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
Lancet. 2002 Jun 1;359(9321):1877-90. doi: 10.1016/s0140-6736(02)08778-0.
7
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
JAMA. 1999 Oct 20;282(15):1453-7. doi: 10.1001/jama.282.15.1453.
8
Economic foundations of cost-effectiveness analysis.
J Health Econ. 1997 Feb;16(1):1-31. doi: 10.1016/s0167-6296(96)00506-1.
9
Interpretation of cost-effectiveness analyses.
J Gen Intern Med. 1998 Oct;13(10):716-7. doi: 10.1046/j.1525-1497.1998.00211.x.
10
Comparing benefits and harms: the balance sheet.
JAMA. 1990 May 9;263(18):2493, 2498, 2501 passim. doi: 10.1001/jama.263.18.2493.
Zotero 插件